Gonorrhoea themed issue

Sexually Transmitted Infections

Volumn 86, Issue 6, 2010, Pages 409-411

  Ison, Catherine A ^a   Hughes, Gwenda ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEPHALOSPORIN;

ANTIBIOTIC RESISTANCE; CHLAMYDIA; EDITORIAL; GONORRHEA; MOLECULAR TYPING; NUCLEIC ACID AMPLIFICATION; PRIMARY PREVENTION; PRIORITY JOURNAL;

DRUG RESISTANCE, MULTIPLE, BACTERIAL; GONORRHEA; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES;

EID: 78449238897     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2010.046821     Document Type: Editorial

References (33)

1. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections:overview and estimates. WHO/HIV-AIDS/2001.02 1-43, 2001.
2. Trotter C, Hughes G, Ison C. Epidemiology in the vaccine era. In: Attardo Genco C, Wetzler L, eds. Neisseria- molecular mechanisms of pathogenesis. Caister Academic Press, 2010, p227-43.
3. Hook EW, Handsfield. Gonococcal infections in the adult. In: Holmes KK, Sparling PF, Mardh PA, et al, eds. Sexually transmitted diseases, 3rd edn: McGraw-Hill, 1999, p451.
4. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther 2009;7:821-34.
5. Lewis DA. The Gonococcus fights back: is this time a knock out? Sex Transm Infect 2010;86:415-21.
6. Cole MJ, Chisholm SA, Hoffmann S, et al. European surveillance of antimicrobial resistance in Neisseria gonorrhoeae. Sex Transm Infect 2010;86:427-32.
7. Unemo M, Shipitsyna E, Domeika M. Recommended antimicrobial treatment of uncomplicated gonorrhoea in 2009 in 11 East European countries: implementation of a Neisseria gonorrhoeae antimicrobial susceptibility programme in this region is crucial. Sex Transm Infect 2010;86:442-4.
8. Florindo C, Pereira R, Boura M, et al. Genotypes and antimicrobial- resistant phenotypes of Neisseria gonorrhoeae in Portugal (2004-2009). Sex Transm Infect 2010;86:449-53.
9. Golparian D, Hellmark B, Fredlund H, et al. Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden. Sex Transm Infect 2010;86:454-60.
10. Sadiq ST, Dave J, Butcher PD. Point-of-care antibiotic susceptibility testing for gonorrhoea: improving therapeutic options and sparing the use of cephalosporins. Sex Transm Infect 2010;86:445-6.
11. Chisholm SA, Mouton JW, Lewis DA, et al. Cephalosprin MIC creep among gonococci: time for a pharmocodynamic rethink? J antimicrob Chemother. Published Online First: 6 Aug 2010.
12. Bignell C, Garley J. Azithromycin in the treatment of infection with Neisseria gonorrhoeae. Sex Transm Infect 2010;86:422-6.
13. Whiley DM, Garland SM, Hamett G, et al. Exploring 'best practice' for nucleic acid detection of Neisseria gonorrhoeae. Sex Health 2008;5:17-23.
14. Health Protection Agency Guidance for gonorrhoea testing in England & Wales 2010. http://www.hpa.org.uk/web/HPAwebFile/HPAweb-C/1267550166455 (accessed 23 Aug 2010).
15. Alexander S. The challenges of detecting gonorrhoea and Chlamydia in rectal and pharyngeal sites: could we, should we, be doing more? Sex Transm Infect 2009;85:182-6.
16. x assay, in extracted mode, for detection of Neisseria gonorrhoeae. Sex Transm Infect 2010;86:465-9.
17. Rockett R, Goire N, Limnios A, et al. Evaluation of the Cobas 4800 CT/NG test for detecting Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Infect 2010;86:470-3.
18. Verma R, Sood S, Bala M, et al. Diagnostic implications of 16S ribosomal assay for gonorrhoea. Sex Transm Infect 2010;86:461-4.
19. Goire N, Nissen MD, Le Cornec GM, et al. A duplex Neisseria gonorrhoeae real-time polymerase chain reaction assay targeting the gonococcal porA pseudogene and multicopy opa genes. Diagn Microbiol Infect Dis 2008;61:6-12. (Pubitemid 351509746)
20. Møller JK. Culture confirmation of gonococcal infection by recall of subjects found to be positive by nucleic acid amplification tests in general practice. Sex Transm Infect 2010;86:478-80.
21. Delpech V, Martin I, Hughes G, et al, on behalf of the GRASP steering group. Epidemiology and clinical presentation of gonorrhoea in England and Wales: findings from the Gonococcal Resistance to Antimicrobials Surveillance Programme 2001-2006. Sex Transm Infect 2009;85:317-21.
22. Berry SA, Ghanem KG, Page KR, et al. Gonorrhea and chlamydia testing rates of HIV-infected men: low despite guidelines. Sex Transm Infect 2010;86:481-4.
23. Sanders EJ, Thiong'o AN, Okuku HS, et al. High prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections among HIV-1 negative men who have sex with men in coastal Kenya. Sex Transm Infect 2010;86:440-1.
24. Kinghorn G. Pharyngeal gonorrhoea: a silent cause for concern. Sex Transm Infection 2010;86:413-14.
25. Tipple C, Smith A, Bakowska E, et al. Corneal perforation requiring corneal grafting: a rare complication of gonococcal eye infection. Sex Transm Infect 2010;86:447-8.
26. Ross JDC. Gonorrhoea: to screen or not to screen? Sex Transm Infect 2010;86:411-12.
27. Downing J, Cook PA, Madden HCE, et al. Management of cases testing positive for gonococcal infection in a community-based chlamydia screening programme. Sex Transm Infect 2010;86:474-7.
28. Nicoll A, Hughes G, Donnelly M. Assessing the impact of national anti-HIV sexual health campaigns: trends in the transmission of HIV and other sexually transmitted infections in England. Sex Transm Infect 2001;77:242-7.
29. Berglund T, Asikainen T, Grutzmeier S, et al. The epidemiology of gonorrhea among men who have sex with men in Stockholm, Sweden, 1990-2004. Sex Transm Dis 2007;34:174-9.
30. Celentano DD, Nelson KE, Lyles CM, et al. Decreasing incidence of HIV and sexually transmitted diseases in young Thai men: evidence for success of the HIV/AIDS control and prevention program. AIDS 1998;12:F29-F36.
31. Taha TE, Dallabetta GA, Hoover DR, et al. Trends of HIV-1 and sexually transmitted diseases among pregnant and postpartum women in urban Malawi. AIDS 1998;12:197-203.
32. Nagot N, Meda N, Ouangre A, et al. Review of STI and HIV epidemiological data from 1990 to 2001 in urban Burkina Faso: implications for STI and HIV control. Sex Transm Infect 2004;80;124-9.
33. Chen MI, Ghani AC. Populations and partnerships: insights from metapopulation and pair models into the epidemiology of gonorrhoea and other sexually transmitted infections. Sex Transm Infect 2010;86:433-9.